Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
they trading below cash and they have 6 drugs awaiting FDA approval including the Big Oxycodone drug which alone has $250-400 Million sales potential and this stock is valued at $11 million if you dont see the big potential here then you should avoid the biotech sector .
stock is undervalued even IF those warrants getting exercised and again im NOT a long term shareholder any jump above $2 i will quitly disappear
Looks like good news is on the way to push stock back above $1 and beyond ..Market cap of $11 million is ridiculous which is below their cash balance of $15 million .Any FDA approval and/or Partnerdeal(s) will let this stock explode to the upside . Fair Value is between $4-5 right now
bought this stock because of the imminent NDA resubmission (this quarter) of the Oxycodone drug which has the highest potential in their pipeline . Once they submit the NDA the big runup will begin and there is a lot of room for runup because of its very low valuation of $10 million thats nothing for a drug close to FDA approval which has hundred of millions of sales potential .Other potential Drug approval(s) during the next 6-8 months will be just a bonus .
Market Cap $10 M / Cash $15 M / 6 Drugs awaiting FDA approval / NDA Resubmission for a BIG Pain Drug this Quarter FDA approval likely in 1H 2019 = Again this is a MASSIVE opportunity for those who looking for underpriced Biotechs with near term milestones
Presentation October 2018
http://secfilings.nasdaq.com/filingFrameset.asp?FilingID=12999325&RcvdDate=10/5/2018&
Ipci valuation is $12 Million at current O/S of 22 Million which is lower than their Cash balance and they have 6 drugs awaiting FDA approval for me its a fantastic opportunity at this ridiculous low price .
For new shareholders at this price its a fantastic entry point , they have now a lot of cash and many major milestones around the corner . FACT is this stock is heavily undervalued at current levels .
Presentation October 2018
http://secfilings.nasdaq.com/filingFrameset.asp?FilingID=12999325&RcvdDate=10/5/2018&
STRONG BUY before NDA Resubmission or any of the Drugs under FDA review getting approved this low float could jump back above $2 or 3 very quickly on good news . This is the perfect time to buy after the company is well financed .
Presentation October 2018
insert-text-here
Deal(s) in the Cannabis area would let this low float explode many other canadian biotechs already active in that sector so im sure IPCI is next with some news in that area.
Big push above $1 will happen anytime now to keep stock on Nasdaq likely on imminent clinical results and NDA resubmission . Its definitely a great buy here to make quick money in the coming weeks and months before FDA decision .GLTA
Bioanalytical samples and statistical analysis for such studies are pending. An update on the results will be provided once the analysis is complete.
The FDA granted our request for an extension to February 28, 2019 to resubmit our NDA for Oxycodone ER under section 505(b)(2) of the U.S. Federal Food, Drug and Cosmetic Act. However, we plan to resubmit the application later this year.
4 Drugs awaiting FDA approval which could happen anytime / NDA Resubmission expected this Quarter /Cash for 2 years / Dirt low valuation = Scam or Not stock is fundamental brutally undervalued so any good news could push this low float stock skyrocketing .Im a short term investor and i think there is good potential to sell this one at multiple higher price before FDA decision .GLTA
NDA resubmission this Quarter will make this stock one of the cheapest FDA play . Garbage or not i dont care because most Biotechs with very low valuation running up fast before FDA decision and thats why im in .
yep bought in below 0.60 for the upcoming FDA runup. i dont think its a mistake buying here close to cash level .
SUPER CHEAP ..NDA resubmission for Oxycodone ER expected by year end so FDA decision will be around May or June ( Class 2 Resubmission 6-month review cycle) . With the cash on hand and the NDA resubmission in near term this stock is very attractive at this price i think $3-4 before FDA decision is likely .
The abuse liability studies for the intranasal route of abuse commenced in May 2018 with subject screening, while the studies to support abuse-deterrent label claims for the oral route of abuse commenced in June 2018. The clinical part of both studies has now been completed. Bioanalytical samples and statistical analysis for such studies are pending. An update on the results will be provided once the analysis is complete.
The FDA granted our request for an extension to February 28, 2019 to resubmit our NDA for Oxycodone ER under section 505(b)(2) of the U.S. Federal Food, Drug and Cosmetic Act. However, we plan to resubmit the application later this year.
$3.9 BILLION UNPROFITABLE PONZI SCHEME BUBBLE / BOOK VALUE LAUGHABLE $3.80 / BURNING $20 MILLION A QUARTER / BRUTAL OVERBOUGHT WITH AN RSI OF 87 = Fantastic short opportunity with a near term tgt of $20
great SHORT opp and here is why
this $8.5 BILLION BUBBLE JUNK HAS MONSTER DEBT OF $1.7 BILLION AND A LAUGHABLE BOOK VALUE OF JUST $18.80 this bubble stock should trade closer to the book value so around $23-25 AT MAX .
SUPER Short Opp today guys
BOOK VALUE LAUGHABLE MINUS $2.20 / P/E 5400 LOL / MONSTER DEBT OF $1.3 BILLION WHICH THEY NEVER CAN REPAY AND VERY LOW CASH BALANCE = STRONG SELLLLLLLL THIS BRUTALLY PUMPED PONZI SCHEME BUBBLE SCAM . FAIR VALUE IS $5-7 AT MAX . WARNING brutal stock promotion ongoing to attract new bagholders so the criminal Banksters and board members can unload their radioactive trash to them dont fall for it guys . gL anyway .
$3.5 BILLION BUBBLE SCAM / BOOK VALUE MINUS $17.77 / MONSTER DEBT OF $2 BILLION = STRONG SELLLLLL THIS BRUTALLY PROMOTED PONZI SCHEME FRAUD.. WARNING brutal stock promo ongoing to attract new bagholders so the criminal banksters and board members can unload their worthless trash to them dont fall for ut guys
Great SHORT opp today ...
V
$3.4 BILLION UNPROFITABLE FRAUD / $150 MILLION DEBT´/ REVENUE COLLAPSING = GREAT SHORT HERE ..Brutal Stock promo ongoing to attract newbies so the criminal Banksters and Management can unlaod their worthless trash to them WARNING .
Share offering after close thats what i smell ..Could drop to mid $20 or lower in the coming days
FANTASTIC SHORT OPP TODAY...
$10 BILLION UNPROFITABLE BUBBLE FRAUD WHICH BURNING $120+ MILLION A QUARTER AN HAVE $200 MILLION DEBT = BRUTAL PONZI SCEHEME FRAUD ONGOING HERE TO ATTRACT NEWBIES SO THE CRIMINAL BANKSTERS AND BOARD MEMEBRS CAN UNLOAD THEIR TRASH = NEXT MEGA SCAM LIKE VALEANT VRX = FAIR VALUE $10 AT BEST
$1.2 BILLION for a one trick pony junk which still has to conduct a large phase 3 trial which will take years to finish is for me definitely brutally overpriced . And a 10 patients trial is a big joke almost every Drug works in such small numbers of patients its even worthless to talk about these results . Oh and look at the dumping by Insiders and Institutions in last days , FMR as an example dumped 1.6 million shares yesterday they know this heavily pumped trash has an astronomical valuation .
$1.2 BILLION Bubble /most advanced drug is in phase 2 for which they released ridiculous results from 10patients . Phase 3 will take minimum 6-8 years untill any results are available means you can expect more dilutions in the coming years . This is one of the most overpriced scam in the sector .
FANTASTIC short opp created today on ridiculous phase 2 results from 10 patients . This one trick pony junk is valued close to $1 billion and they are minimum 7 years away from approval if ever . They burning around $15 million a qurter so there will be many dilutions .
NO Cash / Huge Debt / Business without any growth / book value laughable $7 = Fantastic short opp created today near term tgt $23-25
fantastic short opportunity created today , got some at $30.80 will cover at $30 or lower today .
THIS JUNK HAS $72 MILLION DEBT AND BURNING $25+ MILLION PER QUARTER = ONE OF THE BIGGEST PONZI SCHEME FRAUD OUT THERE . Looks like there is brutal stock promotion ongoing to drive the shorts out of this doomed bankrupt scam so the criminal banksters and management can dumptheir radioactive trash to them .WARNING This Bankrupt Fraud is running out of cash within 4-5 months so the only option they have is MEGA DILUTION or BANKRUPT FILLING maybe thats the reason why the desperate stock promotion so the banksters can run for the hills before its to late for them.FAIR VALUE IS ZERO EVEN THAT IS TO HIGH .
BOOK VALUE LAUGHABLE $0.93 // BURNING $50+ MILLION PER QUARTER = ONE OF THE BIGGEST PONZI SCHEME BUBBLE FRAUD OUT THERE ... This Bankrupt fraud running out of Cash soon maybe thats why the brutal stock promotion to scare the shorts out of this radioactive scam so the criminal banksters and management can dump their worthless trash to them . BE CAREFUL GUYS BECAUSE MONSTER DILUTION OR BANKRUPT FILING IS AROUND THE CORNER .Good luck anyway .
Book Value laughable $3.60 / P/E 30 = fantastic short opportunity today after heavy pumping near term tgt $20-22
Book value laughable $5 / P/E 40 = Fantastic Short opp ,near term tgt $30-33 in long term it will be below $10 .mark this
Price Target Lowered to $17.00 at RBC Capital Markets
https://www.chaffeybreeze.com/2017/03/08/puma-biotechnology-inc-pbyi-price-target-lowered-to-17-00-at-rbc-capital-markets.html
They running out of cash by mid year looks like a great Short opportunity here
$4.7 Billion unprofitable fraud + $1.7 Billion debt and running out of cash = Next Bankrupt scam here = FANTASTIC short opp
$3.2 BILLION UNPROFITABLE SCAM + $700 MILLION DEBT = STRONG SELLLLLLLL THIS BRUTALY PUMPED PONZI SCHEME BUBBLE . Another Scam like Valeant (VRX) here ,fair value is around $5-7 AT MAX .
$1.2 BILLION DEBT / BOOK VALUE LAUGHABE $0.61 / P/E 55 and Jim Cramer is pumping the hell out of this Junk = Fantastic Short opp here near term tgt $100
HEAVY Debt of $11.6 BILLION / Book Value laughable $11 / Revenue collapsing = Fantastic short opp here close at $44 ..Fair Value is $18-20 at best
$31 BILLION FRAUD WITH $3.5 BILLION DEBT AND A MONSTER PE OF 85 = FANTASTIc Short opp ..Fair Value $40-45 at MAX
NO CASH / UNPROFITBALE SCAM = MONSTER DILUTION IMMINENT TO PAVE THE ACQUISITION = BAK TO $10-12 WITHIN DAYS-.BRUTAL STOCK PROMO ONGOING TO SUCK IN NEWBIES SO THA BANKSTERS AND BOARD MEMBER CAN DUMP TO THEM BEFORE MONSTER DILUTION . WARNING
UNBELIEVABLE $71 BILLION DEBT / P/E 120 = ONE OF THE BIGGEST PONZI SCHEME BUBBLE OUT THERE .FAIR VALUE FOR THIS HEAVILY PUMPED FRAUD IS $10-15 AT MAX . Fantastic SHORT opportunity here